<DOC>
	<DOCNO>NCT02539953</DOCNO>
	<brief_summary>One ten patient rivaroxaban therapy dizziness reduction blood pressure . The investigator intend monitor ambulatory blood pressure patient order ass whether true haemodynamic effect .</brief_summary>
	<brief_title>Ambulatory Blood Pressure Monitoring Rivaroxaban Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Aged 1875 year Able provide write , informed consent Taking rivaroxaban indication within license drug , daily twice daily dose include Have measurable rivaroxaban level least one occasion ( line standard care , extra blood sample study ) Not take concomitant medication affect rivaroxaban metabolism ( include amiodarone , dronedarone , azole antifungal , protease inhibitor ) On antihypertensive vasoactive medication Have baseline BP record take clinic Unable provide write , informed consent Presence concomitant medication may alter rivaroxaban level confound result ( see ) Unwilling undergo ambulatory blood pressure monitor Contraindication ambulatory blood pressure monitoring</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>